N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141523 |
| CAS No | NA |
| Mol.F. | C16H16ClFN4O2 |
| Mol.Wt. | 350.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141524 |
| CAS No | 59467-62-8 |
| Mol.F. | C16H12ClFN4O |
| Mol.Wt. | 330.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141525 |
| CAS No | NA |
| Mol.F. | C16H12ClFN4O2 |
| Mol.Wt. | 346.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141526 |
| CAS No | NA |
| Mol.F. | C16H10ClFN4O4 |
| Mol.Wt. | 376.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141527 |
| CAS No | NA |
| Mol.F. | C18H20N2O2 |
| Mol.Wt. | 296.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141528 |
| CAS No | NA |
| Mol.F. | C8H8N8O2 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141529 |
| CAS No | NA |
| Mol.F. | C14H17N7O2 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141530 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141531 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141532 |
| CAS No | NA |
| Mol.F. | C10H11ClN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141533 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141534 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141535 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141536 |
| CAS No | NA |
| Mol.F. | C28H33N3O3 |
| Mol.Wt. | 459.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141537 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141538 |
| CAS No | NA |
| Mol.F. | C26H22FIN6O5 |
| Mol.Wt. | 644.7 |
| INV STATUS | CUSTOM SYNTHESIS |